Cargando…
Recent Development of Novel Aminoethyl-Substituted Chalcones as Potential Drug Candidates for the Treatment of Alzheimer’s Disease
No drug on the market, as a single entity, participates in different pathways involved in the pathology of Alzheimer’s disease. The current study is aimed at the exploration of multifunctional chalcone derivatives which can act on multiple targets involved in Alzheimer’s disease. A series of novel a...
Autores principales: | Sharma, Pratibha, Singh, Manjinder, Singh, Varinder, Singh, Thakur Gurjeet, Singh, Tanveer, Ahmad, Sheikh F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534526/ https://www.ncbi.nlm.nih.gov/pubmed/37764355 http://dx.doi.org/10.3390/molecules28186579 |
Ejemplares similares
-
Scaffold Morphing and In Silico Design of Potential BACE-1 (β-Secretase) Inhibitors: A Hope for a Newer Dawn in Anti-Alzheimer Therapeutics
por: Bhatia, Shiveena, et al.
Publicado: (2023) -
Mitochondrial Dysfunction in Alzheimer’s Disease: Opportunities for Drug Development
por: Bhatia, Shiveena, et al.
Publicado: (2022) -
In Silico Approaches to Developing Novel Glycogen Synthase Kinase 3β (GSK-3β)
por: Goyal, Shuchi, et al.
Publicado: (2023) -
Computational Studies to Understand the Neuroprotective Mechanism of Action Basil Compounds
por: Singh, Varinder, et al.
Publicado: (2023) -
Development of binary dispersions and nanocomposites of irbesartan with enhanced antihypertensive activity
por: Puri, Vivek, et al.
Publicado: (2020)